Hello, everyone, and a very good morning to you. Another shiny day is unfolding here on the Pharmalot corporate campus, where we are hustling assorted short people off to the local schoolhouse and preparing for the usual round of meetings and deadlines. Same with you? Of course. So to prepare, here are a few items of interest. Hope your day goes well and do stay in touch...
Savient Pharmaceuticals Fails To Find A Buyer (Bloomberg News)
Boehringer Prices New Bloodthinner At $6.75 A Day (Reuters)
Celgene Scales Back Expansion Plan (NJ.com)
Walgreen May Sell Its PBM Business (Bloomberg News)
Insurer Pilots Cancer Care Reimbursement For Oncologists (PharmaTimes)
NICE May Not OK Simponi For Rheumatoid Arthritis (PharmaTimes)
Amgen Earnings Beat Estimates Despite Shrinking Sales (Bloomberg News)
Bristol Notches Profits Thanks To Cost Cutting (Reuters)
FDA Should Issue Consent Decree Against J&J (OTC Product News)